Article info
PDFTherapeutics
Systematic review with meta-analysis
B-type natriuretic peptide-guided therapy for chronic heart failure reduces all-cause mortality compared with usual care but does not affect all-cause hospitalisation or survival free of hospitalisation
- Correspondence to A Mark Richards
Cardiovascular Research Institute, National University Heart Centre, Singapore 1 E Kent Ridge Road, NUHS Tower Block, Level 9, Singapore 119228; mdcarthu{at}nus.edu.sg
Citation
B-type natriuretic peptide-guided therapy for chronic heart failure reduces all-cause mortality compared with usual care but does not affect all-cause hospitalisation or survival free of hospitalisation
Publication history
- First published August 5, 2010.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions